GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

HST Global HSTC · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.70

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$523,980

FY2015FY2025

Net income

−$860,695

FY2015FY2025

Free cash flow

−$1.1m

FY2015FY2025

Shareholders' equity

$12.3m

FY2015FY2025

Income statement

Fiscal years

FY2025FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Revenue$523,980—————————
Gross profit$365,898—————————
Operating income−$809,910−$141,000−$141,035−$145,718−$207,978−$151,554−$142,587−$165,092−$137,274−$160,047
Net income−$860,695−$146,000−$145,074−$151,002−$210,006$426,572−$178,335−$165,000−$173,022−$195,795
Diluted earnings per share-0.01-0.03-0.03-0.03-0.040.10-0.08-0.07-0.07-0.08

Balance sheet

At each fiscal year end

FY2025FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Total assets$13.1m$1,526$190$225$660$1,955—$291$465$195
Cash and short-term investments$13,970$1,526$190$225$660$1,955—$291$465$195
Total liabilities$790,098$593,593$446,047$301,008$153,083$5,385$3.4m$3.2m$3.0m$2.9m
Debt$525,829$98,300$76,100$55,100$25,700—$1.4m$1.4m$1.3m$1.3m
Shareholders' equity$12.3m−$592,067−$445,857−$300,783−$152,423−$3,430−$3.4m−$3.2m−$3.0m−$2.9m
Shares outstanding141m5m5m5m5m4m2m2m2m2m

Cash flow

Fiscal years

FY2025FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operations−$1.1m−$20,906−$21,035−$29,836−$26,971−$91,905−$21,091−$29,874−$21,930−$17,569
Capital spending−$4—————————
Free cash flow−$1.1m−$20,906−$21,035−$29,836−$26,971−$91,905−$21,091−$29,874−$21,930−$17,569

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Sept 2024Jun 2024
Revenue$206,059$154,240$275,456$132,189————
Gross profit$165,976$114,157$237,623$92,106−$40,083−$40,083——
Operating income$43,500−$73,708−$164,895−$157,203−$140,915−$115,387−$13,400−$16,556
Net income$5,636−$107,889−$177,379−$163,047−$156,037−$129,425−$13,792−$16,640
Diluted earnings per share0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Total assets$13.3m$13.2m$13.1m$12.9m$12.8m$12.8m$1.3m$5,155
Cash and short-term investments$20,618$9,310$13,970$7,206−$3,413$641$10,406$5,155
Debt$717,360$748,408$525,829$751,967$636,215$548,099$41,600$21,600
Shareholders' equity$12.2m$12.2m$12.3m$11.9m$11.8m$11.9m$1.2m−$17,879

Growth per year

Compound annual rate

3 years5 years10 years
Operating income77.1%39.8%18.5%
Net income78.6%—16.6%

Valuation history

At each fiscal year end

FY2025FY2023
Price to earnings-6.3-0.0
Price to sales10.3—

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return1332%1734%150%20%575%-25%1262%286%36%561%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 15-to-1 reverse split · 26 Nov 2019
  • 25-to-1 reverse split · 7 Jul 2008

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.